CorMedix
CRMD
54 hedge funds and large institutions have $16.2M invested in CorMedix in 2015 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 7 closing their positions.
64% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 14
0.17% more ownership
Funds ownership: 4.59% → 4.76% (+0.17%)
5% less funds holding
Funds holding: 57 → 54 (-3)
41% less capital invested
Capital invested by funds: $27.7M → $16.2M (-$11.5M)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
85% less call options, than puts
Call options by funds: $258K | Put options by funds: $1.77M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.05M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$992K |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$874K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$787K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$471K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
-$503K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$502K |
| 3 |
PG
PEAK6 Group
Chicago,
Illinois
|
-$432K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$175K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$132K |
CRMD Hedge Fund Activity: Q3 2015 in Review
54 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q3 2015, worth a combined $16.2M — down 41% from $27.7M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of CRMD and 4 opened new positions — a net loss of 3 holders — while 14 trimmed existing stakes and 23 added.
The largest buyer was Vanguard Group, adding an estimated $1.05M. The largest seller was Group One Trading, cutting an estimated $503K.
- 54 institutional investors held CorMedix (CRMD) as of Q3 2015, down from 57 in Q2 2015.
- Funds reported $16.2M of CorMedix stock for Q3 2015, down 41% quarter-over-quarter.
- 4 funds opened new CorMedix positions in Q3 2015 and 7 closed out, a net change of -3 holders.
- The largest CorMedix buyer in Q3 2015 was Vanguard Group, an estimated $1.05M added.
- The largest CorMedix seller in Q3 2015 was Group One Trading, an estimated $503K sold.
Based on aggregated 13F filings for Q3 2015.